-
Product Insights
Treatment Resistant Depression – Drugs In Development, 2023
Global Markets Direct’s, ‘Treatment Resistant Depression - Drugs In Development, 2023’, provides an overview of the Treatment Resistant Depression pipeline landscape. The report provides comprehensive information on the therapeutics under development for Treatment Resistant Depression, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Major Depressive Disorder – Drugs In Development, 2023
Global Markets Direct’s, ‘Major Depressive Disorder - Drugs In Development, 2023’, provides an overview of the Major Depressive Disorder pipeline landscape. The report provides comprehensive information on the therapeutics under development for Major Depressive Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TNB-738 in Autoimmune Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TNB-738 in Autoimmune Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TNB-738 in Autoimmune Disorders Drug Details:TNB-738 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GDD-3898 in Non-Alcoholic Steatohepatitis (NASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GDD-3898 in Non-Alcoholic Steatohepatitis (NASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GDD-3898 in Non-Alcoholic Steatohepatitis (NASH)Drug Details:GDD-3898 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabozantinib s-malate in Wilms’ Tumor (Nephroblastoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabozantinib s-malate in Wilms' Tumor (Nephroblastoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabozantinib s-malate in Wilms' Tumor (Nephroblastoma) Drug Details: Cabozantinib s-malate...
-
Product Insights
Ancora Hldgs/ Legal & General Capital – Rhode Island Health Lab – Rhode Island
Equip yourself with the essential tools needed to make informed and profitable decisions with our Ancora Hldgs/ Legal & General Capital - Rhode Island Health Lab - Rhode Island report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
Amarta Group/ Ancora Resdl Fd/ MAJ Group – The MAJ Residences Cibubur – West Java
Equip yourself with the essential tools needed to make informed and profitable decisions with our Amarta Group/ Ancora Resdl Fd/ MAJ Group - The MAJ Residences Cibubur - West Java report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Product Insights
Surgical Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Surgical Heart Valves Pipeline Market Report Overview Surgical heart valves are used in cardiac surgeries to treat heart valves diseases where the affected heart valves are either replaced or repaired. Cardiac valve repair devices and prosthetic heart valves are covered under this category. The surgical heart valves pipeline market research report provides comprehensive information about the surgical heart valves pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which...
-
Product Insights
Cardiac Valve Repair Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Cardiac Valve Repair Pipeline Product Market Cardiac valve repair devices are used in Open-Heart surgery to repair malfunctioning valves. Only mitral valve repair has been covered in this report. Mitral Valve Annuloplasty Devices consist of the annuloplasty rings and bands that are used in the repair of mitral valves. Some of the mitral valve annuloplasty devices covered in this model can be used to repair both the mitral and tricuspid valves. The cardiac valve repair devices pipeline market research report...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TNB-738
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry TNB-738 Drug Details TNB-738 is under development for the treatment of autoimmune disorders. The...